JSA is advising Axis Capital Limited, IIFL Capital Services Limited (formerly known as IIFL Securities Limited), CLSA India Private Limited and SBI Capital Markets Limited, book running lead managers in relation to the proposed initial public offering of equity shares of Veeda Clinical Research Limited (the “Company” and such offering, the “IPO”) comprising a fresh issue of up to INR 1,850 million and an offer for sale of up to 13,008,128 equity shares by certain existing shareholders of the Company.
Deal Value: Fresh Issue of up to ₹ 1,850 million and Offer for Sale of up to 13,008,128 equity shares by certain existing shareholders.
Our transaction team comprised, Lead Partner – Madhurima Mukherjee Saha, Principal Associate – Sagar Batra, and Associates – Bhavini Mohan, Nidhi Prakriti, Aryaman Singh, and Shashwat Sharma.
Madhurima has more than 20 years of experience in securities offerings in the domestic and international markets including initial public offering, further offers, rights offer, qualified institutions placement, InVITs, block trades.